Cargando…

Prevalence of Fabry Disease in Korean Men with Left Ventricular Hypertrophy

BACKGROUND: Fabry disease is an X-linked recessive disorder caused by deficiency of the lysosomal enzyme α-galactosidase A (α-Gal A). Previous studies identified many cases of Fabry disease among men with left ventricular hypertrophy (LVH). The purpose of this study was to define the frequency of Fa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Woo-Shik, Kim, Hyun Soo, Shin, Jinho, Park, Jong Chun, Yoo, Han-Wook, Takenaka, Toshihiro, Tei, Chuwa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6384437/ https://www.ncbi.nlm.nih.gov/pubmed/30804731 http://dx.doi.org/10.3346/jkms.2019.34.e63

Ejemplares similares

A Case of Fabry Cardiomyopathy
por: Nah, Jong Chun, et al.
Publicado: (2009)

A Comparison of Cornell and Sokolow-Lyon Electrocardiographic Criteria for Left Ventricular Hypertrophy in Korean Patients
por: Park, Jin Kyu, et al.
Publicado: (2012)

Screening for Fabry Disease in patients with unexplained left ventricular hypertrophy
por: Sadasivan, Chandu, et al.
Publicado: (2020)

Validation study of candidate single nucleotide polymorphisms associated with left ventricular hypertrophy in the Korean population
por: Park, Jin-Kyu, et al.
Publicado: (2015)

Left ventricular hypertrophy in Fabry disease: a practical approach to diagnosis
por: Yousef, Zaheer, et al.
Publicado: (2013)

The Relationship between Adiponectin and Left Ventricular Mass Index Varies with the Risk of Left Ventricular Hypertrophy
por: Lee, Yonggu, et al.
Publicado: (2013)

Screening for Fabry Disease in Left Ventricular Hypertrophy: Documentation of a Novel Mutation
por: Baptista, Ana, et al.
Publicado: (2015)

Electrocardiographic Left Ventricular Hypertrophy and Outcome in Hemodialysis Patients
por: Kim, Seung Jun, et al.
Publicado: (2012)

Screening for Fabry Disease by Urinary Globotriaosylceramide Isoforms Measurement in Patients with Left Ventricular Hypertrophy
por: Gaggl, Martina, et al.
Publicado: (2016)

Mono-symptomatic Fabry disease in a population with mild-to-moderate left ventricular hypertrophy
por: Fuller, Maria, et al.
Publicado: (2020)

Ascending aorta dilatation common feature which correlate with left ventricular hypertrophy in fabry disease
por: Bensalah, Mourad, et al.
Publicado: (2011)

Interleukin-18 deteriorates Fabry cardiomyopathy and contributes to the development of left ventricular hypertrophy in Fabry patients with GLA IVS4+919 G>A mutation
por: Chien, Yueh, et al.
Publicado: (2016)

Ratio of Fabry disease in patients with idiopathic left ventricular hypertrophy: A single-center study in Turkey
por: Barman, Hasan Ali, et al.
Publicado: (2020)

Correlation research between osteoporosis and left ventricular hypertrophy in older men
por: Huang, Chenshu, et al.
Publicado: (2016)

Unexplained Left Ventricular Hypertrophy Diagnosed as a Cardiac Variant of Late-Onset Fabry Disease: A Case Report
por: Zhao, Maomao, et al.
Publicado: (2023)

Blood Pressure Trajectories for 16 Years and the Development of Left Ventricular Hypertrophy and Increased Left Atrial Size: The Korean Genome and Epidemiology Study
por: Kim, Seong Hwan, et al.
Publicado: (2022)

Prognostic significance of right ventricular hypertrophy and systolic function in Anderson–Fabry disease
por: Graziani, Francesca, et al.
Publicado: (2020)

Moexipril and left ventricular hypertrophy
por: Chrysant, George S, et al.
Publicado: (2007)

Left ventricular hypertrophy: is it really?
por: Mikolich, J Ronald, et al.
Publicado: (2013)

Non-Dipper Status and Left Ventricular Hypertrophy as Predictors of Incident Chronic Kidney Disease
por: An, Hye Rim, et al.
Publicado: (2011)

Fabry Disease and the Effectiveness of Enzyme Replacement Therapy (ERT) in Left Ventricular Hypertrophy (LVH) Improvement: A Review and Meta-Analysis
por: Lee, Chung-Lin, et al.
Publicado: (2022)

ERT impact on left ventricular mass in Fabry disease
por: Ortiz, Alberto
Publicado: (2019)

Impact of Pheochromocytoma on Left Ventricular Hypertrophy and QTc Prolongation: Comparison with Takotsubo Cardiomyopathy
por: Choi, Seon Yoon, et al.
Publicado: (2014)

The distribution of hypertrophy in anderson fabry disease
por: Sado, Daniel M, et al.
Publicado: (2011)

Effect of enzyme replacement therapy on serum asymmetric dimethylarginine levels, coronary flow reserve and left ventricular hypertrophy in patients with Fabry disease
por: Fujii, Hideki, et al.
Publicado: (2012)

The presence of left ventricular hypertrophy in patients with acute type A aortic dissection: weight on the postoperative clinical outcomes
por: Kim, Wan Kee, et al.
Publicado: (2022)

Revised definition of predicted left ventricular mass using ambulatory blood pressure in healthy Korean adults
por: Kim, Bae Keun, et al.
Publicado: (2017)

Myocardial Energetics in Left Ventricular Hypertrophy
por: Jameel, Mohammad N, et al.
Publicado: (2009)

Left Ventricular Hypertrophy and Ventricular Tachyarrhythmia: The Role of Biomarkers
por: Bacharova, Ljuba, et al.
Publicado: (2023)

Association between serum uric acid and left ventricular hypertrophy/left ventricular diastolic dysfunction in patients with chronic kidney disease
por: Kim, Il Young, et al.
Publicado: (2021)

High Prevalence of Late-Onset Fabry Cardiomyopathy in a Cohort of 499 Non-Selective Patients with Left Ventricular Hypertrophy: The Asian Fabry Cardiomyopathy High-Risk Screening Study (ASIAN-FAME)
por: Fan, Yiting, et al.
Publicado: (2021)

The Association Between Left Ventricular Hypertrophy and Biomarkers in Patients on Continuous Ambulatory Peritoneal Dialysis
por: Park, Sang-Ho, et al.
Publicado: (2009)

Endomyocardial biopsies in patients with left ventricular hypertrophy and a common Chinese later-onset fabry mutation (IVS4 + 919G > A)
por: Hsu, Ting-Rong, et al.
Publicado: (2014)

Difficulties in Diagnosing Fabry Disease in Patients with Unexplained Left Ventricular Hypertrophy (LVH): Is the Novel GLA Gene Mutation a Pathogenic Mutation or Polymorphism?
por: Aladağ, N, et al.
Publicado: (2023)

Prehypertension and Left Ventricular Diastolic Dysfunction in Middle-Aged Koreans
por: Jang, Shin Yi, et al.
Publicado: (2016)

Prevalence of papillary muscle hypertrophy in fabry disease
por: Cianciulli, Tomás Francisco, et al.
Publicado: (2023)

Carotid Atherosclerosis and Electrocardiographic Left Ventricular Hypertrophy in the General Population: The Namwon Study
por: Kim, Nam-Ho, et al.
Publicado: (2017)

Electrocardiographic Criteria for Left Ventricular Hypertrophy in Children
por: Rijnbeek, Peter R., et al.
Publicado: (2008)

The Role of ECG in the Diagnosis of Left Ventricular Hypertrophy
por: Bacharova, Ljuba, et al.
Publicado: (2014)

Left ventricular hypertrophy, inflammation, and insulin resistance
por: Öncel, Can Ramazan
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8egq38gqm7alejk6uemeq1lafn